{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:22Z","timestamp":1787021062074,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Limited data exist on psoriatic arthritis (PsA) treatment in lower-income regions, particularly from the patient perspective. This study explores the challenges faced by socioeconomically vulnerable PsA patients and the reasons for non-adherence to treatment guidelines. The main objective of the study is to develop a questionnaire to identify the primary challenges in PsA treatment adherence and to analyze its feasibility while simultaneously understanding the target population\u2019s unique characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included PsA patients meeting the Classification Criteria for PsA (CASPAR), excluding those with other overlapping inflammatory diseases. The study, supported by two patient-research partners, began with focus groups to identify treatment challenges, leading to the creation of a 26-item questionnaire. Its reliability was verified using the test-retest method, targeting a percent agreement\u2009\u2265\u20090.8. Then, PsA patients at a rheumatology clinic completed the final survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study involved 69 PsA patients. The final questionnaire contained 26-questions across five-domains, with a 92.2% agreement rate and an average completion time of 8.3\u00a0minutes. Diagnostic delays exceeded a year for 59% of patients and more than two years for 33%. Daily life disruptions affected 43.2% of patients, with 35.3% taking sick leave or retiring. Around 25% waited over 8 weeks for drug approval, and 17.6% required legal intervention to access medication. Drug dispensation issues impacted about 60% of patients. Furthermore, 66.7% lived far from their rheumatologist, with 49% traveling over an hour for appointments. Approximately 30% were unaware of the risks of methotrexatein relation to alcohol consumption and pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The questionnaire was feasible and reliable, with its results underscoring patient-centric challenges in PsA management, particularly concerning diagnostic delays and medication access, as well as daily life disruptions and misinformation. These findings emphasize the urgency for healthcare reforms aimed at improving diagnosis efficiency, patient education, and streamlined medication access, emphasizing the need for tailored initiatives to improve the healthcare experience for PsA patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42358-024-00414-7","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T04:01:47Z","timestamp":1726718507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of a questionnaire to assess the patient perspective regarding challenges in psoriatic arthritis treatment\u2014a mixed-methods study"],"prefix":"10.1186","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-8924","authenticated-orcid":false,"given":"Andr\u00e9","family":"Lucas Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Andressa","family":"Tessari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Lubianca Kohem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pen\u00e9lope","family":"Esther Palominos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Mendon\u00e7a da Silva Chakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"414_CR1","doi-asserted-by":"crossref","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.","DOI":"10.1136\/bmj.m1590"},{"key":"414_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","volume":"80","author":"F Alinaghi","year":"2019","unstructured":"Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, et al. Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019;80:251\u2013e26519.","journal-title":"J Am Acad Dermatol"},{"key":"414_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957\u201370.","journal-title":"N Engl J Med"},{"issue":"23","key":"414_CR4","first-page":"00134","volume":"S0149\u20132918","author":"AL Ribeiro","year":"2023","unstructured":"Ribeiro AL, Dullius L, Sartori NS, Azeredo-da-Silva A, Kohem CL, Coates L, et al. Challenges in the management of psoriatic arthritis in Latin America: a systematic review. Clin Ther. 2023;S0149\u20132918(23):00134\u20130.","journal-title":"Clin Ther"},{"key":"414_CR5","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s10067-020-04934-7","volume":"39","author":"M Elmamoun","year":"2020","unstructured":"Elmamoun M, Eraso M, Anderson M, Maharaj A, Coates L, Chandran V, et al. International League of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settings. Clin Rheumatol. 2020;39:1839\u20131839.","journal-title":"Clin Rheumatol"},{"key":"414_CR6","doi-asserted-by":"crossref","unstructured":"Espinoza LR, Toloza SMA, Valle-Onate R, Mease PJ. Global partnering opportunities and challenges of psoriasis and psoriatic arthritis in Latin America: a report from the GRAPPA 2010 annual meeting. The Journal of rheumatology. 2012;39:445\u20137.","DOI":"10.3899\/jrheum.111246"},{"key":"414_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.rdc.2016.01.002","volume":"42","author":"A-M Orbai","year":"2016","unstructured":"Orbai A-M, Ogdie A. Patient reported outcomes in Psoriatic Arthritis. Rheum Dis Clin North Am. 2016;42:265\u201383.","journal-title":"Rheum Dis Clin North Am"},{"key":"414_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/annrheumdis-2012-203130","volume":"73","author":"JAB Van Nies","year":"2014","unstructured":"Van Nies JAB, Krabben A, Schoones JW, Huizinga TWJ, Kloppenburg M, Van Der Helm-Van Mil AHM. What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis. 2014;73:861\u201370.","journal-title":"Ann Rheum Dis"},{"key":"414_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74:1045\u201350.","journal-title":"Ann Rheum Dis"},{"key":"414_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/annrheumdis-2016-210242","volume":"76","author":"A-M Orbai","year":"2017","unstructured":"Orbai A-M, de Wit M, Mease P, Shea JA, Gossec L, Leung YY, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76:673\u201380.","journal-title":"Ann Rheum Dis"},{"key":"414_CR11","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","volume":"89","author":"BC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89:1245\u201351.","journal-title":"Acad Med"},{"key":"414_CR12","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665\u201373.","journal-title":"Arthritis Rheum"},{"key":"414_CR13","doi-asserted-by":"crossref","unstructured":"Greenbaum TL. The Handbook for Focus Group Research. SAGE Publications, Inc.; 1998 [cited 2023 Aug 22]. https:\/\/methods.sagepub.com\/book\/the-handbook-for-focus-group-research","DOI":"10.4135\/9781412986151"},{"key":"414_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijnurstu.2017.11.003","volume":"79","author":"MS Park","year":"2018","unstructured":"Park MS, Kang KJ, Jang SJ, Lee JY, Chang SJ. Evaluating test-retest reliability in patient-reported outcome measures for older people: a systematic review. Int J Nurs Stud. 2018;79:58\u201369.","journal-title":"Int J Nurs Stud"},{"key":"414_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pain.2010.03.034","volume":"150","author":"S Perrot","year":"2010","unstructured":"Perrot S, Bouhassira D, Fermanian J, CEDR (cercle d\u2019Etude de la douleur en rhumatologie). Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain. 2010;150:250\u20136.","journal-title":"Pain"},{"key":"414_CR16","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","volume":"41","author":"K Kroenke","year":"2003","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284\u201392.","journal-title":"Med Care"},{"key":"414_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pec.2008.06.005","volume":"73","author":"LM Arnold","year":"2008","unstructured":"Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, et al. Patient perspectives on the impact of Fibromyalgia. Patient Educ Couns. 2008;73:114\u201320.","journal-title":"Patient Educ Couns"},{"key":"414_CR18","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3390\/healthcare11111531","volume":"11","author":"P Montes\u00f3-Curto","year":"2023","unstructured":"Montes\u00f3-Curto P, Panisello-Chavarria ML, Sarri\u00f3-Col\u00e1s L, Toussaint L. Nurses\u2019 perceptions of patient Fibromyalgia Illness experiences after performing group-based problem-solving therapy: a qualitative research study. Healthcare. 2023;11:1531.","journal-title":"Healthcare"},{"key":"414_CR19","first-page":"3315","volume":"157","author":"NS Bojl\u00e9n","year":"1995","unstructured":"Bojl\u00e9n NS, Lunde IM. [Focus group interview as a qualitative research method]. Ugeskr Laeger. 1995;157:3315\u20138.","journal-title":"Ugeskr Laeger"},{"key":"414_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4103\/ija.IJA_334_19","volume":"63","author":"S Yaddanapudi","year":"2019","unstructured":"Yaddanapudi S, Yaddanapudi LN. How to design a questionnaire. Indian J Anaesth. 2019;63:335\u20137.","journal-title":"Indian J Anaesth"},{"key":"414_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4300\/JGME-D-13-00154.1","volume":"5","author":"GB Willis","year":"2013","unstructured":"Willis GB, Artino AR. What do our respondents think we\u2019re asking? Using Cognitive interviewing to improve medical education surveys. J Grad Med Educ. 2013;5:353\u20136.","journal-title":"J Grad Med Educ"},{"key":"414_CR22","doi-asserted-by":"crossref","first-page":"237437352199884","DOI":"10.1177\/2374373521998847","volume":"8","author":"MK Rooney","year":"2021","unstructured":"Rooney MK, Santiago G, Perni S, Horowitz DP, McCall AR, Einstein AJ, et al. Readability of patient education materials from high-impact medical journals: a 20-Year analysis. J Patient Exp. 2021;8:2374373521998847.","journal-title":"J Patient Exp"},{"key":"414_CR23","unstructured":"Associa\u00e7\u00e3o Brasileira de Empresas de Pesquisa (ABEP). Crit\u00e9rio de Classifica\u00e7\u00e3o Econ\u00f4mica Brasil. 2022 [cited 2024 Jan 5]. https:\/\/www.abep.org\/criterio-brasil"},{"key":"414_CR24","unstructured":"Standards for reporting. qualitative research: a synthesis of recommendations| EQUATOR Network. [cited 2023 Mar 3]. https:\/\/www.equator-network.org\/reporting-guidelines\/srqr\/"},{"key":"414_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","volume":"67","author":"M Boers","year":"2014","unstructured":"Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d\u2019Agostino M-A, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol. 2014;67:745\u201353.","journal-title":"J Clin Epidemiol"},{"key":"414_CR26","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/rheumatology\/kez505","volume":"59","author":"F Iannone","year":"2020","unstructured":"Iannone F, Nivuori M, Fornaro M, Venerito V, Cacciapaglia F, Lopalco G. Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis. Rheumatology (Oxford). 2020;59:1599\u2013606.","journal-title":"Rheumatology (Oxford)"},{"key":"414_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42358-019-0104-6","volume":"60","author":"Y Ulus","year":"2019","unstructured":"Ulus Y, Akyol Y, Bilgici A, Kuru O. The impact of the presence of fibromyalgia on fatigue in patients with psoriatic arthritis: comparison with controls. Adv Rheumatol. 2019;60:1.","journal-title":"Adv Rheumatol"},{"key":"414_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s42358-022-00271-2","volume":"62","author":"AP de Sousa","year":"2022","unstructured":"de Sousa AP, de Arruda GT, Pontes-Silva A, de Souza MC, Driusso P, Avila MA. Measurement properties of the Brazilian online version of the Fibromyalgia Rapid Screening Tool (FiRST). Adv Rheumatol. 2022;62:39.","journal-title":"Adv Rheumatol"},{"key":"414_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.23736\/S1973-9087.21.06432-7","volume":"58","author":"A-N Ll\u00e0dser","year":"2022","unstructured":"Ll\u00e0dser A-N, Montes\u00f3-Curto P, L\u00f3pez C, Rossell\u00f3 L, Lear S, Toussaint L, et al. Multidisciplinary rehabilitation treatments for patients with fibromyalgia: a systematic review. Eur J Phys Rehabil Med. 2022;58:76\u201384.","journal-title":"Eur J Phys Rehabil Med"},{"key":"414_CR30","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/j.1742-1241.2007.01480.x","volume":"61","author":"A Berger","year":"2007","unstructured":"Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61:1498\u2013508.","journal-title":"Int J Clin Pract"},{"key":"414_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","volume":"18","author":"LC Coates","year":"2022","unstructured":"Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol. 2022;18:465\u201379.","journal-title":"Nat Rev Rheumatol"},{"key":"414_CR32","doi-asserted-by":"crossref","unstructured":"Piovesan DM, Busato VB, da Silveira RG, do Prado AD, Molina-Bastos CG, Hickmann S, et al. Quality of referrals to a rheumatology service before and after implementation of a triage system with telemedicine support. Adv Rheumatol (London, England). 2021;61. https:\/\/pubmed.ncbi.nlm.nih.gov\/34284822\/","DOI":"10.1186\/s42358-021-00203-6"},{"key":"414_CR33","doi-asserted-by":"publisher","first-page":"e2250211","DOI":"10.1001\/jamanetworkopen.2022.50211","volume":"6","author":"KB Patel","year":"2023","unstructured":"Patel KB, Turner K, Alishahi Tabriz A, Gonzalez BD, Oswald LB, Nguyen OT, et al. Estimated indirect cost savings of using Telehealth among nonelderly patients with Cancer. JAMA Netw Open. 2023;6:e2250211.","journal-title":"JAMA Netw Open"},{"key":"414_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/annrheumdis-2011-201063","volume":"72","author":"E Villeneuve","year":"2013","unstructured":"Villeneuve E, Nam JL, Bell MJ, Deighton CM, Felson DT, Hazes JM, et al. A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis. Ann Rheum Dis. 2013;72:13\u201322.","journal-title":"Ann Rheum Dis"},{"key":"414_CR35","doi-asserted-by":"publisher","first-page":"e000152","DOI":"10.1136\/rmdopen-2015-000152","volume":"1","author":"M van Onna","year":"2015","unstructured":"van Onna M, Gorter S, Maiburg B, Waagenaar G, van Tubergen A. Education improves referral of patients suspected of having spondyloarthritis by general practitioners: a study with unannounced standardised patients in daily practice. RMD Open. 2015;1:e000152.","journal-title":"RMD Open"},{"key":"414_CR36","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3899\/jrheum.140857","volume":"42","author":"BDM Tom","year":"2015","unstructured":"Tom BDM, Chandran V, Farewell VT, Rosen CF, Gladman DD. Validation of the Toronto Psoriatic Arthritis Screen Version 2 (ToPAS 2). J Rheumatol. 2015;42:841\u20136.","journal-title":"J Rheumatol"},{"key":"414_CR37","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1056\/NEJMp1501140","volume":"372","author":"J Macinko","year":"2015","unstructured":"Macinko J, Harris MJ. Brazil\u2019s Family Health Strategy \u2014 Delivering Community-based primary care in a Universal Health System. N Engl J Med. 2015;372:2177\u201381.","journal-title":"N Engl J Med"},{"key":"414_CR38","doi-asserted-by":"publisher","first-page":"e1002306","DOI":"10.1371\/journal.pmed.1002306","volume":"14","author":"T Hone","year":"2017","unstructured":"Hone T, Rasella D, Barreto ML, Majeed A, Millett C. Association between expansion of primary healthcare and racial inequalities in mortality amenable to primary care in Brazil: a national longitudinal analysis. PLoS Med. 2017;14:e1002306.","journal-title":"PLoS Med"},{"key":"414_CR39","doi-asserted-by":"crossref","unstructured":"Da Silva MRR, Dos Santos JBR, Almeida AMI, Alvares-Teodoro J, Kakehasi AM, Acurcio FDA. Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation. Adv Rheumatol (London, England). 2019;59. https:\/\/pubmed.ncbi.nlm.nih.gov\/31727164\/","DOI":"10.1186\/s42358-019-0091-7"},{"key":"414_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-019-0960-z","volume":"18","author":"CM Vargas-Pelaez","year":"2019","unstructured":"Vargas-Pelaez CM, Rover MRM, Soares L, Blatt CR, Mantel-Teeuwisse AK, Rossi FA, et al. Judicialization of access to medicines in four latin American countries: a comparative qualitative analysis. Int J Equity Health. 2019;18:1\u201314.","journal-title":"Int J Equity Health"},{"key":"414_CR41","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1590\/1413-81232022276.16282021","volume":"27","author":"HC Capucho","year":"2022","unstructured":"Capucho HC, Brito A, Maiolino A, Kaliks RA, Pinto RP. Incorporation of medicines in the Unified Health System (SUS): comparison between oncology and the specialized component of pharmaceutical care. Cien Saude Colet. 2022;27:2471\u20139.","journal-title":"Cien Saude Colet"},{"key":"414_CR42","doi-asserted-by":"publisher","first-page":"e0215837","DOI":"10.1371\/journal.pone.0215837","volume":"14","author":"JM Phuong","year":"2019","unstructured":"Phuong JM, Penm J, Chaar B, Oldfield LD, Moles R. The impacts of medication shortages on patient outcomes: a scoping review. PLoS ONE. 2019;14:e0215837.","journal-title":"PLoS ONE"},{"key":"414_CR43","doi-asserted-by":"crossref","unstructured":"de Moraes JCB, de Ribeiro ACM, Bonfiglioli KR, Miossi R, Shimabuco AY, Bonfa E, et al. Assisted therapy model for dispensing immunobiological drugs for rheumatoid arthritis by the Brazilian Unified Health System: rational use of resources reduces expenses. BJHE. 2022; http:\/\/jbes.com.br\/wp-content\/uploads\/2022\/03\/JBES-Especialingles-31-37.pdf","DOI":"10.21115\/JBES.v14.n1.(Supl.1):31-7"},{"key":"414_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12916-016-0674-7","volume":"14","author":"S Iyengar","year":"2016","unstructured":"Iyengar S, Hedman L, Forte G, Hill S. Medicine shortages: a commentary on causes and mitigation strategies. BMC Med. 2016;14:124.","journal-title":"BMC Med"},{"key":"414_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42358-020-00131-x","volume":"60","author":"G Santin","year":"2020","unstructured":"Santin G, Da Silva MMM, Villarreal VA, Laste LDD, De Freitas Montin E, Betiol LER, et al. Home storage of biological medications administered to patients with rheumatic diseases. Adv Rheumatol. 2020;60:1\u20138.","journal-title":"Adv Rheumatol"},{"key":"414_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5152\/eurjrheum.2019.18182","volume":"6","author":"MA Saavedra","year":"2019","unstructured":"Saavedra MA, Aimo C, Andrade JA, Alvarez D, Sequeira G, Kerzberg E. Survey on transportation and storage of biological therapies by patients. Eur J Rheumatol. 2019;6:92\u20135.","journal-title":"Eur J Rheumatol"},{"key":"414_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12969-020-00455-4","volume":"18","author":"J Roszkiewicz","year":"2020","unstructured":"Roszkiewicz J, Swacha Z, Smolewska E. Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA. Pediatr Rheumatol. 2020;18:64.","journal-title":"Pediatr Rheumatol"},{"key":"414_CR48","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1007\/s12325-019-01101-6","volume":"36","author":"I Usach","year":"2019","unstructured":"Usach I, Martinez R, Festini T, Peris J-E. Subcutaneous Injection of Drugs: literature review of factors influencing Pain Sensation at the Injection Site. Adv Ther. 2019;36:2986\u201396.","journal-title":"Adv Ther"},{"key":"414_CR49","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s10067-020-05555-w","volume":"40","author":"DG Fern\u00e1ndez-\u00c1vila","year":"2021","unstructured":"Fern\u00e1ndez-\u00c1vila DG, Patino-Hernandez D, Kowalskii S, Vargas-Caselles A, Sapag AM, Cachafeiro-Vilar A, et al. Current status of the rheumatologists\u2019 workforce in Latin America: a PANLAR collaborative study. Clin Rheumatol. 2021;40:2913\u201320.","journal-title":"Clin Rheumatol"},{"key":"414_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00393-017-0297-1","volume":"76","author":"A Zink","year":"2017","unstructured":"Zink A, Braun J, Gromnica-Ihle E, Krause D, Lakomek HJ, Mau W, et al. [Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016]. Z Rheumatol. 2017;76:195\u2013207.","journal-title":"Z Rheumatol"},{"key":"414_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/RHU.0000000000000515","volume":"23","author":"C Pineda","year":"2017","unstructured":"Pineda C, Sandoval H, Sheen R, Mu\u00f1oz-Louis RPANLAR, Presidency FS-AR. 2014\u20132016: challenges, opportunities, and results. J Clin Rheumatology: Practical Rep Rheumatic Musculoskelet Dis. 2017;23:107\u201312.","journal-title":"J Clin Rheumatology: Practical Rep Rheumatic Musculoskelet Dis"},{"key":"414_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1472-6963-9-86","volume":"9","author":"T B\u00e4rnighausen","year":"2009","unstructured":"B\u00e4rnighausen T, Bloom DE. Financial incentives for return of service in underserved areas: a systematic review. BMC Health Serv Res. 2009;9:86.","journal-title":"BMC Health Serv Res"},{"key":"414_CR53","first-page":"581","volume":"6","author":"TJ Kotzee","year":"2006","unstructured":"Kotzee TJ, Couper ID. What interventions do South African qualified doctors think will retain them in rural hospitals of the Limpopo province of South Africa? Rural Remote Health. 2006;6:581.","journal-title":"Rural Remote Health"},{"key":"414_CR54","doi-asserted-by":"crossref","unstructured":"Grobler L, Marais BJ, Mabunda SA, Marindi PN, Reuter H, Volmink J. Interventions for increasing the proportion of health professionals practising in rural and other underserved areas. Cochrane Database Syst Rev. 2009:CD005314.","DOI":"10.1002\/14651858.CD005314.pub2"},{"key":"414_CR55","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/annrheumdis-2014-206807","volume":"74","author":"HA Zangi","year":"2015","unstructured":"Zangi HA, Ndosi M, Adams J, Andersen L, Bode C, Bostr\u00f6m C, et al. EULAR recommendations for patient education for people with inflammatory arthritis. Ann Rheum Dis. 2015;74:954\u201362.","journal-title":"Ann Rheum Dis"},{"key":"414_CR56","first-page":"112","volume":"30","author":"TE Paterick","year":"2017","unstructured":"Paterick TE, Patel N, Tajik AJ, Chandrasekaran K. Improving health outcomes through patient education and partnerships with patients. Proc (Bayl Univ Med Cent). 2017;30:112\u20133.","journal-title":"Proc (Bayl Univ Med Cent)"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-024-00414-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-024-00414-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-024-00414-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T06:02:13Z","timestamp":1732773733000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-024-00414-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["414"],"URL":"https:\/\/doi.org\/10.1186\/s42358-024-00414-7","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"4 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects willingly signed an Informed Consent Form, which had been approved by the Hospital de Cl\u00ednicas de Porto Alegre\u2019s ethics committee (Certificado de Apresenta\u00e7\u00e3o de Aprecia\u00e7\u00e3o \u00c9tica\u2014CAAE\u2014number 66326122.6.0000.5327).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}